imeglimin
AssetAlso EMD-387008
Improves mitochondrial function, reduces oxidative stress, increases intracellular NAD+, and suppresses high glucose-induced cellular senescence.
- Stage
- Preclinical
- Modality
- Small molecule
- Target
- Oxidative stress and ROS signalling
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Diabetic neuropathy
Preclinical, doi.org, 5 Jun 2026
In the full profile
- Targets and what it contains5
- Owner and partners1
- Evidence for its targets6
- Competitors12
- Aging relevance2
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.